According to a new study published in the Journal of Affective Disorders, inhaled marijuana temporarily mitigates symptoms of post-traumatic stress (PTS), including anxiety and flashbacks. The study is titled Short and long-term effects of cannabis on symptoms of post-traumatic stress disorder.
According to a new study published in the European Journal of Pain, delivering a precise doses of THC via a specialized inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions. The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial, was first published by NORML.
According to an interesting and for some eye-opening new study published in the journal Drug and Alcohol Dependence, the enactment of marijuana legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions.
According to a new study published in the journal Frontiers in Psychology, longitudinal studies fail to suggest that prenatal marijuanaexposure is independently associated with “clinically significant” cognitive impairments in either children or young adults. The study, conducted by researchers affiliated with Columbia University and with the New York State Psychiatric Institute, was first reported on by NORML.
According to a new study published in the journal BMC Public Health, jurisdictions that regulate marijuana use should consider imposing a minimum age requirement of 19.
For the study researchers examined life outcomes (including educational attainment and mental health) associated with the use of marijuana: They studies this across various age groups.
According to a new study, even though Uruguay legalized marijuana for all uses for those 18+ seven years ago (the first country to do so), youth marijuana use in the country is not higher than it was prior to legalization.
“In 2013, Uruguay became the first country in the world to legalize recreational cannabis, instituting a non-commercial state regulatory model of production and supply”, states the study’s absract. “This study provides the first empirical evidence on its impacts on adolescent use of cannabis and related risks.”
According to a new study published in the journal Nature: Human Behavior, police are less likely to conduct searches for illicit contraband during a traffic stop following the enactment of adult-use marijuana legalization, but people of color are still targeted at unfair rates.
According to a new study published in the Journal of Concurrent Disorders, those who consistently use medical cannabis show little to no difference in their driving performance following cannabis inhalation. The study, titled Effects of therapeutic cannabis on simulated driving: A pilot study, was first reported on by NORML.
For the study, researchers from the University of Toronto, Health Canada, and the Centre for Addiction and Mental Health examined the influence of marijuana inhalation on simulated driving performance among a group of daily medical marijuana consumers. “Participants were asked to refrain from engaging in any cannabis use during the 48 hours immediately prior to the study sessions. Fourteen subjects completed the study.” Subjects performed on a driving simulator prior to and 30 minutes after inhaling cannabis. Three separate driving scenarios were programmed into the simulator.
A multi-week treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes, according to a new study. The study is being published in the journal Neuroscience Letters, and it was epublished ahead of print by the U.S. National Institute of Health. The study is titled Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes.
Article updated in May 2020 adding new resources and studies to the article
A study conducted by researchers at the Roskamp Institute in Florida, and published in the journal Molecular and Cellular Neuroscience, has found that cannabis can slow the effects of Alzheimer’s Disease, and may in fact be able to halt it entirely.
According to Corbin Bachmeier, Ph.D – who’s the lead researcher of the study – Alzheimer’s Disease is “the result of impaired Aβ [Amyloid-β protein] clearance from the brain”. According to this study, cannabis can solve this problem, making it a potential treatment.
Here’s the study’s abstract: